Gene description for MAPK1 |
Gene name |
mitogen-activated protein kinase 1 |
Gene symbol |
MAPK1 |
Other names/aliases |
ERK ERK-2 ERK2 ERT1 MAPK2 NS13 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk p42-MAPK |
Species |
Homo sapiens |
Experiment description of studies that identified MAPK1 in Plasma |
1
|
Experiment ID | 473 |
Identified molecule | protein
|
Extracellular vesicle type | Microparticles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
23056467
|
Organism | Homo sapiens |
Experiment description | Cause or Effect of Arteriogenesis: Compositional Alterations of Microparticles from CAD Patients Undergoing External Counterpulsation Therapy. |
Authors | Al Kaabi A, Traupe T, Stutz M, Buchs N, Heller M. |
Journal name |
PLoS One
|
Publication year | 2012 |
Sample | Plasma |
Sample name | Patients of external counterpulsation therapy-Blood |
Isolation/purification methods | - |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
-
|
|
|
2
|
Experiment ID | 2848 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | Small EVs |
Identification method | Mass spectrometry
|
PubMed ID |
35058437
|
Organism | Homo sapiens |
Experiment description | Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2 |
Authors | El-Shennawy L, Hoffmann AD, Dashzeveg NK, McAndrews KM, Mehl PJ, Cornish D, Yu Z, Tokars VL, Nicolaescu V, Tomatsidou A, Mao C, Felicelli CJ, Tsai CF, Ostiguin C, Jia Y, Li L, Furlong K, Wysocki J, Luo X, Ruivo CF, Batlle D, Hope TJ, Shen Y, Chae YK, Zhang H, LeBleu VS, Shi T, Swaminathan S, Luo Y, Missiakas D, Randall GC, Demonbreun AR, Ison MG, Kalluri R, Fang D, Liu H. |
Journal name |
Nat Commun
|
Publication year | 2022 |
Sample | Plasma |
Sample name | NWL-001 - Lung cancer patient |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Western blotting Mass spectrometry |
EV-TRACK |
-
|
|
|
3
|
Experiment ID | 2130 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | Small EVs |
Identification method | ELISA
|
PubMed ID |
36515353
|
Organism | Homo sapiens |
Experiment description | Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin |
Authors | Vreones M, Mustapic M, Moaddel R, Pucha KA, Lovett J, Seals DR, Kapogiannis D, Martens CR. |
Journal name |
Aging Cell
|
Publication year | 2023 |
Sample | Plasma |
Sample name | Patient-derived neuronal origin EVs (enriched) |
Isolation/purification methods | ExoQuick Kit Centrifugation |
Flotation density | - |
Molecules identified in the study | Metabolite Protein |
Methods used in the study | Mass spectometry Luciferase assay ELISA |
EV-TRACK |
-
|
|
|
4
|
Experiment ID | 2131 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | Small EVs |
Identification method | ELISA
|
PubMed ID |
36515353
|
Organism | Homo sapiens |
Experiment description | Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin |
Authors | Vreones M, Mustapic M, Moaddel R, Pucha KA, Lovett J, Seals DR, Kapogiannis D, Martens CR. |
Journal name |
Aging Cell
|
Publication year | 2023 |
Sample | Plasma |
Sample name | Patient-derived neuronal origin EVs (enriched) |
Isolation/purification methods | ExoQuick Kit Centrifugation |
Flotation density | - |
Molecules identified in the study | Metabolite Protein |
Methods used in the study | Mass spectometry Luciferase assay ELISA |
EV-TRACK |
-
|
|
|
5
|
Experiment ID | 2132 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | Small EVs |
Identification method | ELISA
|
PubMed ID |
36515353
|
Organism | Homo sapiens |
Experiment description | Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin |
Authors | Vreones M, Mustapic M, Moaddel R, Pucha KA, Lovett J, Seals DR, Kapogiannis D, Martens CR. |
Journal name |
Aging Cell
|
Publication year | 2023 |
Sample | Plasma |
Sample name | Patient-derived neuronal origin EVs (enriched) - responders |
Isolation/purification methods | ExoQuick Kit Centrifugation |
Flotation density | - |
Molecules identified in the study | Metabolite Protein |
Methods used in the study | ELISA |
EV-TRACK |
-
|
|
|
6
|
Experiment ID | 2133 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | Small EVs |
Identification method | ELISA
|
PubMed ID |
36515353
|
Organism | Homo sapiens |
Experiment description | Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin |
Authors | Vreones M, Mustapic M, Moaddel R, Pucha KA, Lovett J, Seals DR, Kapogiannis D, Martens CR. |
Journal name |
Aging Cell
|
Publication year | 2023 |
Sample | Plasma |
Sample name | Patient-derived neuronal origin EVs (enriched) - responders |
Isolation/purification methods | ExoQuick Kit Centrifugation |
Flotation density | - |
Molecules identified in the study | Metabolite Protein |
Methods used in the study | ELISA |
EV-TRACK |
-
|
|
|